Abbott Biologicals B.V.
UkraineAll drugs from this manufacturer
-
The drug is used to regulate bowel rhythm in cases of constipation, to facilitate defecation (for example, in cases of hemorrhoids or after intestinal surgery), as well as for the treatment and prevention of hepatic encephalopathy.
Dosage form: syrup
Active substance Dosage lactulose 667 mg/ml ATC: A06AD11
-
The drug is used to treat constipation and regulate intestinal rhythm. It also helps in conditions requiring easier defecation (for example, in case of hemorrhoids or after intestinal surgery), as well as for the treatment and prevention of hepatic coma or precoma.
Dosage form: solution, oral
Active substance Dosage lactulose 667 mg/ml ATC: A06AD11
-
The drug is used for irregular menstrual cycles, endometriosis, painful menstruation (dysmenorrhea), infertility due to luteal phase deficiency, as well as to support pregnancy in cases of threatened miscarriage or recurrent miscarriage. It is also used to support the luteal phase during assisted reproductive technologies and to prevent endometrial hyperplasia during menopause.
Dosage form: tablets, film-coated
Active substance Dosage dydrogesterone 10 mg ATC: G03DB01
-
The drug is used for hormone replacement therapy to alleviate symptoms caused by estrogen deficiency in women during menopause (not earlier than 6 months after the last menstruation). It is also used for the prevention of osteoporosis in postmenopausal women at high risk of fractures.
Dosage form: tablets, film-coated
Active substance Dosage estradiol 1 mg or 1 mg/10 mg dydrogesterone 0 ATC: G03FB08
-
The drug is used for hormone replacement therapy to alleviate symptoms caused by estrogen deficiency in women during menopause (not earlier than 6 months after the last menstruation). It is also used for the prevention of osteoporosis in postmenopausal women at high risk of fractures.
Dosage form: tablets, film-coated
Active substance Dosage estradiol 2 mg or 2 mg/10 mg dydrogesterone 0 ATC: G03FB08
-
The drug is used for hormone replacement therapy to alleviate symptoms caused by estrogen deficiency in women during menopause (not earlier than 12 months after the last menstruation). It is also used for the prevention of osteoporosis in postmenopausal women at high risk of fractures.
Dosage form: tablets, film-coated
Active substance Dosage estradiol 1 mg dydrogesterone 5 mg ATC: G03FA14
-
The drug is used for hormone replacement therapy to alleviate symptoms caused by estrogen deficiency in women during the postmenopausal period (not earlier than 12 months after the last menstruation).
Dosage form: tablets, film-coated
Active substance Dosage estradiol 0.5 mg dydrogesterone 2.5 mg ATC: G03FA14